(FNX) First Trust Mid Cap Core - Ratings and Ratios
Mid-Cap, Equity, Alpha-Seeking, Multi-Sector
Dividends
| Dividend Yield | 0.56% |
| Yield on Cost 5y | 0.94% |
| Yield CAGR 5y | 14.04% |
| Payout Consistency | 97.5% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 18.1% |
| Value at Risk 5%th | 29.5% |
| Relative Tail Risk | -0.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.16 |
| Alpha | -8.58 |
| CAGR/Max DD | 0.60 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.454 |
| Beta | 0.984 |
| Beta Downside | 1.028 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.97% |
| Mean DD | 5.47% |
| Median DD | 4.46% |
Description: FNX First Trust Mid Cap Core November 16, 2025
The First Trust Mid-Cap Core AlphaDEX® Fund (FNX) aims to allocate at least 90 % of its net assets-including any investment-borrowings-to the securities that compose its underlying AlphaDEX® index. The index screens the NASDAQ US 600 Mid-Cap Index for stocks that the AlphaDEX® model predicts will deliver positive alpha, i.e., risk-adjusted outperformance versus conventional market benchmarks.
As of the most recent filing, FNX carries an expense ratio of 0.55 % and manages roughly $1.2 billion in assets, with a sector tilt toward technology (≈30 % of holdings) and consumer discretionary (≈20 %). Recent macro trends-such as the Federal Reserve’s incremental rate hikes and a resilient U.S. consumer spending outlook-tend to favor mid-cap firms that are more agile than large caps yet possess sufficient scale to benefit from economic expansion. The fund’s 12-month rolling Sharpe ratio has hovered around 0.85, indicating a risk-adjusted return profile that modestly exceeds the broader mid-cap market.
For a deeper dive into FNX’s factor exposures and how its AlphaDEX® selections compare to other mid-cap strategies, you might find ValueRay’s analytical tools useful for uncovering hidden performance drivers.
What is the price of FNX shares?
Over the past week, the price has changed by +1.07%, over one month by +3.57%, over three months by +2.80% and over the past year by +6.09%.
Is FNX a buy, sell or hold?
What are the forecasts/targets for the FNX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 141.6 | 10.2% |
FNX Fundamental Data Overview December 02, 2025
Beta = 1.28
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.18b USD (1.18b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.18b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.18b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.64% (E(1.18b)/V(1.18b) * Re(9.64%) + (debt-free company))
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for FNX ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle